Supply of anti-haemophilic factor medicines for the GHT 44 and GHT 49 joint purchasing group – 6 lots

Summary

The tender concerns the supply of anti-haemophilic factor medicines in 6 lots for a joint purchasing group formed by GHT 44 and GHT 49, coordinated by Nantes University Hospital. Each lot will be awarded as a framework agreement implemented through purchase orders, with only a maximum quantity specified. The agreements may be renewed 3 times for one-year periods, and the planned initial contract period is 1 January to 31 December 2027. Electronic submission is required by 8 October 2026 at 12:00. Variants are not allowed, e-invoicing is required and the tender must remain valid for 6 months. Precise bidder qualification, exclusion and compliance requirements must be checked in the tender documents.